Tag: Low phosphate

Over 70% of patients receiving the intravenous iron formulation ferric carboxymaltose (FCM) experience hypophosphatemia, or low phosphate, within weeks of treatment. The answer to "do iron infusions cause low phosphate?" is yes, but the risk varies significantly depending on the specific product used. This emerging safety concern is mediated by a complex hormonal pathway involving FGF23.

Drug-induced hypophosphatemia is frequently observed in clinical settings, with some estimates suggesting a prevalence in up to 10% of hospitalized patients with alcohol use disorder. Understanding **what drugs cause low phosphate levels** is crucial for healthcare providers to ensure patient safety and proper management.